Clinical trials
MicroRNAs clinical trials
Below are recruiting micrornas clinical trials, each written for real people, not researchers. We’re tracking 37 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06939751Recruiting
Testing microRNA levels to personalize heart transplant care
This trial is studying whether a blood test that measures small molecules called microRNAs can help doctors personalize the medicines used to prevent rejection after a heart transplant. If you qualify, you would help researchers learn how to better match immunosuppression to each patient's needs.
Los Angeles, CaliforniaAges 18–99 - NCT03905746Recruiting
Study tests microRNA markers in worsened liver cirrhosis
This study looks at microRNA (tiny molecules in blood) to better understand what’s happening during sudden worsening of cirrhosis. It may help doctors recognize and monitor decompensated cirrhosis more accurately.
LyonAges 18 years+ - NCT03635255Recruiting
Testing heart disease blood markers to predict heart events
This study looks at tiny molecules in your blood to see how they relate to future heart problems in people with coronary artery disease or other cardiovascular disease. If your results suggest higher or lower risk, it may help doctors better predict who could have adverse cardiovascular outcomes.
TaipeiAges 20 years+ - NCT06532890Recruiting
Using microRNAs to personalize heart transplant medicines in children
This study is looking at heart transplant children (up to age 18) to see if measuring tiny molecules called microRNAs in the blood can help doctors personalize anti-rejection medicines. It aims to improve how we prevent rejection while reducing side effects.
Aurora, ColoradoAges Up to 18 years - NCT06529614Recruiting
Study of a microRNA detection test in healthy people
This trial tests a new way to detect tiny molecules called microRNAs in the body. It is looking for healthy volunteers to help see how well the detection works.
Wuhan, HubeiAges 18–75 - NCT06189755Recruiting
MicroRNA markers for sleep apnea
This trial is studying tiny molecules in the blood (called microRNAs) to see if they can help diagnose or monitor obstructive sleep apnea. It compares people with moderate to severe sleep apnea who are starting PAP therapy with people who do not have sleep apnea.
Columbus, OhioAges 18–75 - NCT05937594Recruiting
Testing microRNA markers to spot newborn opioid withdrawal
This study looks at tiny genetic signals (microRNA) in newborn samples to identify neonatal opioid withdrawal syndrome. It may help doctors recognize withdrawal sooner, so babies can get the right care faster.
Hershey, PennsylvaniaAges 1 day–5 days - NCT05392582Recruiting
Study tiny gene signals to calm inflammation with aging
This trial studies tiny gene-like signals (microRNAs) to understand and reduce long-term inflammation as people get older. It may help researchers learn how aging affects inflammation and could guide future treatments.
Salt Lake City, UtahAges 18 years+ - NCT05437588Recruiting
Blood-based biomarkers for suicide risk in teens with depression
This study looks at tiny blood particles (exosomes) and specific microRNAs to see if they can signal suicide risk and predict treatment outcomes in adolescents. If you qualify, your blood may be used to help researchers find better ways to understand and track suicidality and depression treatment response.
Birmingham, AlabamaAges 10–24 - NCT05089747Recruiting
Study uses extra blood samples for solid cancer patients
This study looks at how blood can help us better understand solid cancers. You may be able to join if you’re an adult with solid cancer and your usual care already involves taking blood, and you can safely provide samples for the study.
BronAges 18 years+ - NCT04923685Recruiting
Study looks at blood markers linked to childhood trauma and suicide risk
This study checks whether tiny genetic signals in blood (microRNAs) are linked to childhood maltreatment and thoughts or risk of suicide, especially in people with major depression. It may help researchers understand biological clues that could someday guide better care.
Birmingham, AlabamaAges 18–60 - NCT04771871RecruitingPhase 2
Study tiny RNA changes in triple-negative breast cancer
This trial studies patterns of microRNA (tiny gene-regulating molecules) in women with triple-negative breast cancer. By comparing these microRNA profiles, the study hopes to better understand the disease and potentially guide future treatment choices.
Ile-Ife, OshunAges 18–70 - NCT04406831Recruiting
Testing microRNA for pancreatic cancer diagnosis and treatment response
This study looks at tiny molecules in your body (microRNA) to help doctors better diagnose pancreatic cancer, predict how it may progress, and understand how it responds to treatment. It may help guide more personalized care in the future.
Norwalk, ConnecticutAges 18 years+
Hear when a new MicroRNAs trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for micrornas?
- Yes. Clin2 currently lists 37 recruiting micrornas studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a micrornas trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a micrornas trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.